Repetitive Blood Brain Barrier Opening for Alzheimer's Disease.
NCT06158789 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 6
Last updated 2023-12-06
Summary
This study was focused on comparing the efficacy of repetitive Focused ultrasound mediated BBB opening in alzhemer's disease in increased number of treatment session and shorter intervals.
Conditions
- Alzheimer Disease
Interventions
- PROCEDURE
-
MR guided low intensity focused ultrasound
Low intensity focused ultrasound opens the blood brain barrier
Sponsors & Collaborators
-
Yonsei University
collaborator OTHER -
Kyung Won Chang
lead OTHER
Principal Investigators
-
Jin Woo Chang, MD,PhD · Yonsei University
-
Byoung Seok Ye, MD,PhD · Yonsei University
-
Kyung Won Chang, MD · Yonsei University
-
Kyung Won Chang, MD,PhD · Yonsei University
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 50 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-06-02
- Primary Completion
- 2023-07-19
- Completion
- 2024-01-19
Countries
- South Korea
Study Locations
More Related Trials
-
Neuronavigation-guided FUS-induced BBB Opening in Alzheimer's Disease Patients and Its Effects on Brain Amyloid and Tau
NCT06600880 ·Status: NOT_YET_RECRUITING ·Phase: PHASE1
-
Multi-modal Neuroimaging in Alzheimer's Disease IMAP+
NCT01638949 ·Status: COMPLETED ·Phase: NA
-
Cerebellar ITBS Mode Transcranial Magnetic Stimulation for the Treatment of Alzheimer's Disease
NCT06379100 ·Status: COMPLETED ·Phase: NA
-
MECHANISMS OF NEURONAL RESILIENCE IN ALZHEIMER'S DISEASE AND ITS FOCAL VARIANTS: A PET/MR STUDY
NCT04150198 ·Status: RECRUITING ·Phase: NA
-
Blood-Brain Barrier Opening Using MR-Guided Focused Ultrasound in Patients With Amyotrophic Lateral Sclerosis
NCT03321487 ·Status: COMPLETED ·Phase: NA
-
Biodistribution, Pharmacokinetics, and Safety of F-18 THK-5351 PET in Alzheimer's Disease Patients and Healthy Subjects.(Positron Emission Tomograph )
NCT02686216 ·Status: COMPLETED ·Phase: PHASE1
-
Multi-modal Neuroimaging in Alzheimer's Disease
NCT01554202 ·Status: UNKNOWN ·Phase: NA
-
FluoroAv45 Imaging Research-in Alzheimer's Disease
NCT01325259 ·Status: COMPLETED ·Phase: PHASE2
-
Development of Multimodal Fusion Warning System and Non-invasive Techniques for Early Alzheimer's Detection.
NCT05978830 ·Status: UNKNOWN ·Phase: NA
-
Impact of FBB PET Amyloid Imaging in Change of Diagnosis in Patients With AD
NCT02681172 ·Status: COMPLETED ·Phase: PHASE4
-
Biomarker Study to Diagnose Alzheimer's Disease
NCT01874418 ·Status: UNKNOWN ·Phase: NA
-
Efficacy and Safety of the PET Imaging Agent [18F]NAV4694 in Subjects With Probable Alzheimer's Disease
NCT01680588 ·Status: UNKNOWN ·Phase: PHASE2
-
Neuro Imaging and Multimodal Alzheimer's Disease
NCT02839187 ·Status: COMPLETED ·Phase: NA
-
Study of the Indications for Amyloid Positon Emission Tomography (PET) Scans and Their Usefulness for Patients With Suspected Alzheimer's Disease (AD)
NCT06467981 ·Status: COMPLETED
-
An Exploratory Study of Deep Cervical Lymphovenous Bypass (LVB) in Alzheimer's Disease
NCT06448975 ·Status: RECRUITING ·Phase: NA
-
Magnetic Resonance Elastography in Patients With Acute Closed Traumatic Brain Injury
NCT04361578 ·Status: UNKNOWN
-
Imaging of Atherosclerosis With 68Ga-MSA
NCT01889693 ·Status: COMPLETED
-
A Positron Emission Tomography (PET) Study to Investigate the Brain Biodistribution of 18F GSK2647544 in Healthy Subjects to Determine Its Ability to Cross the Blood-brain-barrier.
NCT01924858 ·Status: TERMINATED ·Phase: PHASE1
-
Evaluation of [18F]PI-2620 as a Potential Positron Emission Computed Tomography Radioligand for Imaging Tau Protein in the Brain
NCT03510572 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Impact of Microglial Activation on Synaptic Density in Alzheimer's Disease
NCT05911178 ·Status: RECRUITING ·Phase: NA
-
HP Xenon-129 fMRI of Healthy Volunteers and Participants With Alzheimer's Disease
NCT02638519 ·Status: TERMINATED ·Phase: EARLY_PHASE1
-
Safety and Efficacy of Positron Emission Tomography (PET) Imaging With MNI-558
NCT01217021 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Beta-Amyloid Imaging With [18F]NAV4694 PET in Predicting Progression to AD in Subjects MCI
NCT01812213 ·Status: TERMINATED ·Phase: PHASE2
-
Influence of Age on Amyloid Load in Alzheimer's Disease and in Atypical Focal Cortical Alzheimer's Disease
NCT01095744 ·Status: COMPLETED
-
Neuroinflammation and Cognitive Decline in Alzheimer Disease
NCT02377206 ·Status: COMPLETED ·Phase: EARLY_PHASE1